IP Library › Assignment 035714/0886
Patent Assignment
Reel/Frame 035714/0886

Release of Security Interest

Recorded: 2015-05-26 Pages: 5
Assignor
ROSSE ENTERPRISES, LTD.
Executed: 2012-01-31
Assignee
AERIS THERAPEUTICS, LLC.
10K GILL STREET, WOBURN, MASSACHUSETTS, 01801
Covered Properties (12)
Tissue Volume Reduction
Patent: 6,610,043 →
Application: 09/379,460 →
Tissue Volume Reduction
Patent: 6,682,520 →
Application: 09/839,253 →
Publication: US 2001/0051799
Tissue Volume Reduction
Patent: 7,654,998 →
Application: 10/069,307 →
Compositions and methods for reducing lung volume
Application: 10/464,115 →
Publication: US 2004/0047855
Tissue Volume Reduction
Patent: 7,654,999 →
Application: 10/649,232 →
Publication: US 2004/0038868
Tissue Volume Reduction
Patent: 7,300,428 →
Application: 11/009,379 →
Publication: US 2005/0239685
Compositions and Methods for Reducing Lung Volume
Patent: 7,819,908 →
Application: 11/016,548 →
Publication: US 2005/0244401
Polycation-polyanion complexes, compositions and methods of use thereof
Application: 11/590,664 →
Publication: US 2007/0110813
Respiratory Assistance Apparatus and Method
Patent: 7,861,710 →
Application: 11/824,942 →
Publication: US 2008/0115787
Lung Volume Reduction Therapy Using Crosslinked Biopolymers
Patent: 8,911,750 →
Application: 12/062,189 →
Publication: US 2008/0261884
Lung Volume Reduction Therapy Using Crosslinked Non-Natural Polymers
Patent: 8,198,365 →
Application: 12/117,367 →
Publication: US 2008/0281352
Polymer Systems for Lung Volume Reduction Therapy
Patent: 8,361,484 →
Application: 12/443,021 →
Publication: US 2010/0040538
Related Assignments (15)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 22, 2011
From: AERIS THERAPEUTICS, INC.
To: AERIS THERAPEUTICS, LLC
Reel/Frame 026170/0254 →
Security Agreement Feb 9, 2012
From: AERIS THERAPEUTICS, LLC
To: ROSSE ENTERPRISES, LTD.
Reel/Frame 027683/0003 →
Assignment of Assignor's Interest May 26, 2015
From: AERIS THERAPEUTICS, LLC.
To: PULMONX CORPORATION
Reel/Frame 035715/0265 →
Security Interest May 15, 2017
From: PULMONX CORPORATION
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 042466/0349 →
Security Interest Jul 26, 2017
From: PULMONX CORPORATION
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043349/0725 →
Assignment of Assignor's Interest Mar 25, 2019
From: AERIS THERAPEUTICS, LLC.
To: PULMONX
Reel/Frame 048682/0506 →
Merger Apr 23, 2019
From: PULMONX
To: PULMONX CORPORATION
Reel/Frame 048964/0822 →
Security Interest Mar 2, 2020
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 052916/0213 →
Release of Security Interest Sep 30, 2020
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: PULMONX CORPORATION
Reel/Frame 053952/0044 →
Release of Security Interest Sep 30, 2020
From: BOSTON SCIENTIFIC CORPORATION
To: PULMONX CORPORATION
Reel/Frame 053953/0548 →
Security Interest Nov 30, 2022
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 061929/0750 →
Security Interest Jan 27, 2026
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 074570/0001 →
Security Interest Mar 2, 2026
From: PULMONX CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS V, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 075012/0453 →
Release of Security Interest Mar 4, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: PULMONX CORPORATION
Reel/Frame 075028/0274 →
Release of Security Interest Mar 5, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: PULMONX CORPORATION
Reel/Frame 073980/0673 →